John Ryan

John Ryan, MD, is the Head of the Rare Disease & Cardiometabolic Commercial Business Unit at Regeneron Pharmaceuticals, Inc., where they manage the commercialization of products within this specialty area. They previously held various roles at Regeneron, including Early Stage Pipeline Strategy Lead and Libtayo Global Marketing Lead. John completed a residency in the Department of Radiology at George Washington University Hospital and worked as an Associate in Biotechnology Equity Research at Jefferies. They earned their M.D. from Columbia University Vagelos College of Physicians and Surgeons and a B.S. in Molecular, Cellular, and Developmental Biology from Yale University.